Racing Force Group and Bahrain International Circuit Announce Completion of Bell Racing Helmets Factory Extension and Groundbreaking for New OMP Production Facility
Major expansion of Racing Force Group production facilities located at The Home of Motorsport in the Middle East.
New OMP factory reflects Racing Force Group's long-term commitment to Bahrain as leader in motorsports safety equipment
MANAMA, BAHRAIN / ACCESSWIRE / November 4, 2024 / Racing Force Group, the leading supplier of motorsports safety products and Bahrain International Circuit (BIC), "The Home of Motorsport in the Middle East", announced today the completion of the extension of the Bell Racing Helmets factory at BIC, together with the groundbreaking for a new production hub for OMP located adjacent to the Bell Racing Helmets facility. Bell Racing Helmets and OMP are both part of Racing Force Group and these latest developments reflect the long-term commitment to Bahrain of a notable motorsport company.
Racing Force is the leading motorsports safety products group with the most advanced and comprehensive range of protection and performance products used worldwide by top professionals, amateur drivers, race teams and car manufacturers sold under brands such as Bell Racing Helmets, OMP, Zeronoise and Racing Spirit. Products under the Group's brands can be found in all world championships of car and kart racing, contributing to several victories and titles each year.
The completion of the Bell Racing Helmets extension has enabled the company to double its production capacity, with a facility that now covers 12,000 sqm. The factory produces a racing helmets range developed for countless racing disciplines including 70% of drivers on the FIA Formula 1 World Championship grid, as well as the collectible Bell Mini Helmets which replicate in 1:2 scale the models used by the stars of global motorsport.
Meanwhile, construction has now commenced on a new factory for OMP, a leading designer and manufacturer of racewear, car parts and accessories to provide safety in motorsport under the Racing Force Group. The new 15,000 sqm facility, located adjacent to the existing one at BIC, will enable the company to produce a selection of its key motorsport safety products at the new factory.
Racing Force Group has recently completed a capital increase, which has allowed Bahrain Mumtalakat Holding Company ("Mumtalakat") to become a strategic investor in the Group through a fully owned subsidiary. This investment aims to meet the rising global demand for motorsports safety products and will support the development of the new OMP facility, further enhancing the Group's position as a leader in safety systems for motorsports.
Sheikh Salman bin Isa Al Khalifa, Chief Executive of Bahrain International Circuit, said:
"The completion of the Bell Racing Helmets factory extension and the start of work on the new OMP facility are two further milestones in the fruitful partnership that we enjoy with Racing Force Group. We are delighted to be able to support such historic and respected brands in global motorsport. Our partnership reflects BIC's position as the Home of Motorsport in the Middle East in its broadest sense and I thank all the entities in Bahrain that facilitate our endeavors, in particular Mumtalakat."
Stephane Cohen, Co-CEO of Racing Force Group and CEO of Racing Force Bahrain, commented:
"Since 2015, our partnership with Bahrain International Circuit has become increasingly close, ensuring us the best conditions and resources to confirm ourselves as the leading manufacturer of state-of-the-art motorsport helmets. The completion of the Sakhir factory extension is another key step in this highly successful alliance. Starting from Bell Racing Helmets, the link with the Bahrain International Circuit now includes the entire Racing Force Group, and following Mumtalakat's investment we can announce the beginning of construction of a second building in Sakhir. The facility will be a strategic asset for increasing the overall production of items in the OMP range, another benchmark brand in the racing industry. On behalf of the entire Group, I want to the thank once again the Bahrain International Circuit organization, CE Sheikh Salman bin Isa Al Khalifa, Mumtalakat, and the Bahrain local community for their constant support."
For more information, please contact:
Abdulelah Abdulla
Communications Department
Economic Development Board
Phone: +973-39798919
E-mail: internationalmedia@bahrainedb.com
SOURCE: Bahrain Economic Development Board
View the original press release on accesswire.com
Bahrain Economic Development Board
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
ProteinQure to Present Data on PQ203, a Novel Peptide-Drug Conjugate for Triple Negative Breast Cancer, at 2024 San Antonio Breast Cancer Symposium6.12.2024 12:30:00 CET | Press release
TORONTO, ON / ACCESSWIRE / December 6, 2024 / ProteinQure, the leading company in computational design of peptide therapeutics, will be presenting compelling new data on the progress of their lead triple negative breast cancer (TNBC) drug PQ203 (December 12, 2024 presentation ID: P4-12-17) at the 2024 San Antonio Breast Cancer Symposium. PQ203 is a novel Peptide Drug Conjugate composed of a Sortilin receptor targeting peptide conjugated to the cytotoxic agent monomethyl auristatin E. The Sortiin receptor is expressed in a high percentage of diseased tissue from TNBC patients and as such represents an innovative treatment for this challenging sub-type of breast cancer. ProteinQure has recently generated data that PQ203 exhibits potent efficacy in a patient-derived xenograft (PDX) model resistant to Sacituzumab Govitecan (Trodelvy™), an antibody drug conjugate that is the emerging standard of care for metastatic TNBC. Additionally, PQ203 has shown an encouraging safety profile. Based on
CNS Pharmaceuticals to Host Virtual Analyst & Investor Day on December 11, 20245.12.2024 09:10:00 CET | Press release
Live webcast discussion featuring internationally renowned Glioblastoma Multiforme (GBM) Key Opinion Leaders Company committed to addressing the most aggressive type of brain cancer with an average survival of only 14 to 16 months after diagnosis and no cure Register for the event here HOUSTON, TX / ACCESSWIRE / December 5, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced it will host a Virtual Analyst & Investor Day on Wednesday, December 11th from 11:30 AM - 1:00 PM ET. For the event, John Climaco, Chief Executive Officer, Sandra Silberman, MD, PhD, Chief Medical Officer and Zena Muzyczenko, Vice President of Clinical Operations at CNS Pharmaceuticals will be joined by Key Opinion Leaders: Michael Weller, Prof. Dr. med. Director of Department, Department of Neurology, Universitatsspital, Zur
Polaris Renewable Energy Successfully Settles USD 175 Million Bond Issue4.12.2024 16:05:00 CET | Press release
TORONTO, ON / ACCESSWIRE / December 4, 2024 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris" or the "Company") announces that it has successfully settled a previously announced private placement of USD 175 million senior secured green bonds. The bonds will have a tenor of five years and a fixed coupon rate of 9.5% percent per annum, with interest payable in semi-annual instalments. Furthermore, the Green Bond will include a tap feature, allowing for access to an additional USD $50 million in funding for potential future uses. The bond issue is rated BB- by S&P Global Ratings and is issued under the Company's green finance framework with second-party opinion from Morningstar Sustainalytics. Marc Murnaghan, Chief Executive Officer of Polaris comments: "We are very pleased to successfully settle this inaugural bond issue with strong interest from a wide set of international investors. The bond optimizes the Company's capital structure and secures financing for further growth and incre
Autobrains and JOYNEXT Revolutionize Smart Camera Solution Powered by Autobrains’ Affordable Safety ADAS Software4.12.2024 04:00:00 CET | Press release
Driving the Future of Safety: Cost-Effective, AI-Powered ADAS Solutions for Global OEMs MUNICH, GERMANY | DRESDEN, GERMANY | TEL AVIV, ISRAEL / ACCESSWIRE / December 4, 2024 / Autobrains, a leader in automotive artificial intelligence (AI), has joined forces with JOYNEXT, a global automotive Tier-1 supplier and development partner to renowned car manufacturers for over 20 years, to offer their groundbreaking Smart Camera ADAS solution. The camera hardware and optimized control software, provided by JOYNEXT, is powered by Autobrains' Affordable Safety ADAS software. The single-box Smart Camera solution, optimized for cost-effective Advanced Driver Assistance Systems (ADAS), was designed to meet the evolving needs of global Original Equipment Manufacturers (OEMs). This compact system simplifies integration, reduces costs, and ensures regulatory compliance without sacrificing performance. With ever increasing global regulations, smart cameras are a must-have in new build vehicles. The joi
IXOPAY and Aperia Compliance Merge to Extend Advanced Payment Data Security to Merchant Acquirers and Merchants of All Sizes, Worldwide4.12.2024 00:00:00 CET | Press release
Merger combines IXOPAY's enterprise-grade capabilities in payment orchestration and tokenization with Aperia Compliance's PCI DSS Level 3 and 4 solutions. TULSA, OKLAHOMA / ACCESSWIRE / December 4, 2024 / IXOPAY, a leading payments technology provider handling more than $35 billion in payment volume through its enterprise-grade payment orchestration platform, announced today that it has merged with Aperia Compliance, a subsidiary of Aperia Solutions and a leading firm in Payment Card Industry Data Security Standard (PCI DSS) data validation and risk management. Serving more than 100 merchant acquirers, Aperia Compliance will operate as "Aperia Compliance, an IXOPAY company." IXOPAY offers enterprise-grade PCI DSS Level 1 and 2 solutions powered by advanced tokenization. Paired with Aperia Compliance's robust PCI DSS Level 3 and 4 solutions-including PCI Apply 4.0 and the new 6.4.3 product-the combined offering aims to deliver a scalable, end-to-end solution enabling merchants, independ
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom